|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03692 HANSOH PHARMA
Nominal 
17.360 -0.340 (-1.921%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Turnover | 6,505,501 | 44.207% | 4,511,217 | 4,434,378 | 4,401,501 | 3,979,518 |
| Cost of Sales | (579,218) | 8.173% | (535,455) | (398,582) | (415,680) | (357,865) |
| Gross Profit | 5,926,283 | 49.060% | 3,975,762 | 4,035,796 | 3,985,821 | 3,621,653 |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 3,118,186 | 107.895% | 1,499,883 | 1,509,124 | 1,547,056 | 1,493,594 | |
| Taxation | (392,661) | 86.064% | (211,035) | (211,148) | (256,466) | (271,760) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 2,725,525 | 111.470% | 1,288,848 | 1,297,976 | 1,290,590 | 1,221,834 | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Net Finance Costs / (Income) | (369,068) | 8.079% | (341,480) | (123,146) | (37,134) | (63,174) |
| Depreciation & Amortisation | 216,767 | 17.249% | 184,878 | 158,167 | 135,251 | 109,118 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| EPS (cts) | 46.000 | 109.091% | 22.000 | 22.000 | 22.000 | 21.000 |
| DPS (cts) | 18.347 | -- | 6.472 | 4.377 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | 39.885% | -- | 29.418% | 19.896% | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 4.701 | -- | 4.075 | 3.567 | 3.161 | 2.973 |
| Remarks: | Real time quote last updated: 06/11/2024 13:50 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 2,725,525 |
| %Change | 111.470% |
| EPS / (LPS) | RMB 0.460 |
| NBV Per Share (¥) | RMB 4.701 |